CellaVision AB 每股年股息为 2.25,收益率为 0.00%。股息每 每年 支付,最近的除息日为 May 7, 2025。
股息收益率
年度股息
除息日
0.00%
$2.25
May 7, 2025
支付频率
派息比率
每年
0.00%
股息历史
除息日
现金金额
记录日期
付款日期
May 7, 2025
$2.50
May 8, 2025
May 13, 2025
May 6, 2024
$2.25
May 7, 2024
May 13, 2024
May 8, 2023
$2.25
May 9, 2023
May 12, 2023
May 12, 2022
$2.00
May 13, 2022
May 18, 2022
Apr 30, 2021
$0.75
May 3, 2021
May 6, 2021
May 9, 2019
$1.50
May 10, 2019
May 15, 2019
股息图表
CVLLY 股息
CVLLY 股息增长率(同比)
Follow-Up Questions
CellaVision AB 当前的股息支付和年度股息是多少?
CellaVision AB 的股息支付比率是多少?
CVLLY 的除息日是什么?
CellaVision AB 多久支付一次股息?
关键数据
前收盘价
--
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
--
每股收益(TTM)
--
股息收益率
--
市值
--
什么是 CVLLY?
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 230 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.